Swedish nanotechnology company secures financing deal
Gothenburg-based nanobiotechnology company Nanoxis has secured a SEK1.75m (€196,226) financing deal.
Gothenburg-based nanobiotechnology company Nanoxis has secured a SEK1.75m (€196,226) financing deal.
The investors are Creandum, The Technology Link Foundation in Gothenburg (TBSG), The Holding Company at the University of Goeteborg (GU Holding) and Chalmersinvest. The company is currently developing nanoanalytical platforms (proteinchips) for identification of certain proteins important for drug development and the biotech industry.
Nanoxis was founded in November 2002 as a spin off from Chalmers University of Technology. Its patent portfolio provides technology solutions for design and production of compact and scalable nanofluidic and nanoelectronic circuits as well as systems for nanoscale templating and nanorobotics.
In the short term the company is focusing on platforms for separation and quantification of certain single target proteins. Specifically, the company is developing nanofabrication methods as well as integrated nanodevices in soft materials with exceptional and unique properties. The research team has developed generic protocols for production of novel components and devices based on special liquid crystalline and polymeric materials combining small scale and complex function.
'We are among the first Swedish companies building a product portfolio on inventions in the area of nanotechnology,' says ceo Ahmet Senoglu. 'Nanoxis's patent portfolio will open up new possibilities for fabrication of complex small scale devices in a number of application areas.'